Rise and shine, everyone. Another hot day is on the way. All the more reason to stay in your air-conditioned office and get lots of work done, yes? While you consider the possibilities, please join us for a refreshing cup of stimulation, or a bottle of water, if you prefer. And, of course, here are some tidbits from around your world. Hope your day goes well and you keep cool. Catch you soon...
Pfizer To Buy Icagen For $56 Million (Associated Press)
Allergan To Buy Vicept For Up To $275 Million (Reuters)
Biotech Draws A 46 Percent Rise In Venture Capital (Bloomberg News)
J&J And Pfizer Alzheimer's Drug May Prove Safer Than Thought (Reuters)
AstraZeneca To Face Trial Over Seroquel Marketing In Arkansas (Bloomberg News)
Obesity Rate Is 30 Percent In 12 US States, CDC Reports (Bloomberg News)
Eisai Stunned By NICE Rejection Of Breast Cancer Drug (Pharma Times)
CRO Strategic Deal Renewals Will Turn On Pricing (Outsourcing Pharma)
Pfizer Must Treat Contaminated Groundwater Site (The Courier-News)
Changes In Australian Rx Subsidies Could Hurt Patients: Docs (Sydney Morning Herald)
South Africa Looks To Open State-Owned Pharma Company (TimesLive)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr